LON:HVO hVIVO (HVO) Share Forecast, Price & News GBX 15.51 -0.24 (-1.52%) (As of 03:32 AM ET) Add Compare Share Share Today's Range 15.51▼ 15.7950-Day Range 14.15▼ 1952-Week Range 9.20▼ 23.40Volume115,702 shsAverage Volume2.25 million shsMarket Capitalization£104.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsDividendInsider TradesHeadlinesProfileChartCompetitorsDividendInsider TradesHeadlines About hVIVO (LON:HVO) StockhVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies. The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services. hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.Read More Receive HVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address HVO Stock News HeadlinesMay 16, 2023 | finance.yahoo.comOne hVIVO Insider Raised Their Stake In The Previous YearMay 16, 2023 | finance.yahoo.comOne hVIVO Insider Raised Their Stake In The Previous Year \June 1, 2023 | Legacy Research (Affiliate) (Ad)The “Amazon Secret Royalty Program” Can Help Anyone Retire Like RoyaltyA unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.April 30, 2023 | finance.yahoo.comDespite shrinking by UK£15m in the past week, hVIVO (LON:HVO) shareholders are still up 100% over 3 yearsApril 27, 2023 | americanbankingnews.comhVIVO plc (HVO) to Issue Dividend of GBX 0.45 on June 9thApril 25, 2023 | finance.yahoo.comhVIVO reveals audited results for "transformational" 2022March 9, 2023 | finance.yahoo.comhVIVO plc (HVO.L)March 8, 2023 | finance.yahoo.comIs hVIVO plc (LON:HVO) Worth UK£0.2 Based On Its Intrinsic Value?June 1, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.February 12, 2023 | msn.comThis ex-penny stock is up 111% in 6 weeks. Should I buy more?February 4, 2023 | msn.com3 no-brainer UK shares to buy in FebruaryFebruary 3, 2023 | finance.yahoo.comWe Might See A Profit From hVIVO plc (LON:HVO) SoonJanuary 26, 2023 | lse.co.ukHvivo Plc Share Price (HVO.GB.PL)January 10, 2023 | finance.yahoo.comFollowing a 34% decline over last year, recent gains may please hVIVO plc (LON:HVO) institutional ownersJanuary 7, 2023 | fool.co.uk1 penny stock I’m buying right now!December 8, 2022 | finance.yahoo.comIs hVIVO plc (LON:HVO) Potentially Undervalued?December 7, 2022 | uk.finance.yahoo.com1 penny stock under 13p I’d snap up right nowNovember 17, 2022 | finance.yahoo.comInvestors in hVIVO (LON:HVO) have unfortunately lost 52% over the last yearOctober 26, 2022 | proactiveinvestors.comhVIVO is a world leader in testing infectious and respiratory disease products using human challenge clinical trialsDecember 16, 2020 | lse.co.ukOpen Orphan Share ChatJanuary 20, 2020 | www.lse.co.ukHvivo Plc Share ChatJanuary 17, 2020 | www.lse.co.ukOpen Orphan Takeover Of hVIVO Now Wholly UnconditionalJanuary 14, 2020 | www.lse.co.ukOpen Orphan To Mount Compulsory Buyout To Get hVIVO Deal Over LineJanuary 6, 2020 | www.lse.co.ukHvivo Share News (HVO)December 31, 2019 | www.lse.co.ukOpen Orphan Meets Acceptance Condition For Merger With hVIVODecember 19, 2019 | www.finanznachrichten.deHVIVO PLCOctober 10, 2019 | finance.yahoo.comCan hVIVO (LON:HVO) Afford To Invest In Growth?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address HVO Company Calendar Last Earnings4/19/2018Ex-Dividend for 6/9 Dividend5/04/2023Today6/01/2023Dividend Payable6/09/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:HVO Previous SymbolLON:RVG CUSIPN/A CIKN/A Webhvivo.com Phone+44-20-77561300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio23.02 P/E GrowthN/ANet Income£-1,060,000.00 Net Margins-1.53% Pretax MarginN/A Return on Equity-3.80% Return on Assets8.20% Debt Debt-to-Equity Ratio7.73 Current Ratio1.42 Quick Ratio1.16 Sales & Book Value Annual Sales£50.70 million Price / Sales2.08 Cash FlowGBX 3.19 per share Price / Cash Flow4.94 Book ValueGBX 3 per share Price / Book5.25Miscellaneous Outstanding Shares671,048,000Free FloatN/AMarket Cap£105.69 million OptionableNot Optionable Beta1.10 Key ExecutivesDr. Yamin Mohammed Khan Ph.D. (Age 54)CEO & Director Mr. Stephen PinkertonCFO & Exec. DirectorMr. Andrew CatchpoleChief Scientific OfficerDr. Maurice N. Treacy Ph.D.Chief Commercial OfficerMs. Teja Marathe-SarvadikarHead of QAKey CompetitorsAgronomicsLON:ANICe-therapeuticsLON:ETXVerseonLON:VSNTiziana Life SciencesLON:TILSRedx PharmaLON:REDXView All Competitors HVO Stock - Frequently Asked Questions How have HVO shares performed in 2023? hVIVO's stock was trading at GBX 10 at the beginning of the year. Since then, HVO shares have increased by 57.5% and is now trading at GBX 15.75. View the best growth stocks for 2023 here. How were hVIVO's earnings last quarter? hVIVO plc (LON:HVO) posted its quarterly earnings results on Thursday, April, 19th. The company reported ($16.50) EPS for the quarter, missing the consensus estimate of ($10.90) by $5.60. hVIVO had a negative trailing twelve-month return on equity of 3.80% and a negative net margin of 1.53%. How often does hVIVO pay dividends? What is the dividend yield for hVIVO? hVIVO declared a dividend on Tuesday, April 25th. Investors of record on Thursday, May 4th will be given a dividend of GBX 0.45 per share on Friday, June 9th. This represents a yield of 2.65%. The ex-dividend date is Thursday, May 4th. The official announcement can be viewed at this link. Read our dividend analysis for HVO. What other stocks do shareholders of hVIVO own? Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY). What is hVIVO's stock symbol? hVIVO trades on the London Stock Exchange (LON) under the ticker symbol "HVO." How do I buy shares of hVIVO? Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is hVIVO's stock price today? One share of HVO stock can currently be purchased for approximately GBX 15.75. How much money does hVIVO make? hVIVO (LON:HVO) has a market capitalization of £105.69 million and generates £50.70 million in revenue each year. How can I contact hVIVO? hVIVO's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The official website for the company is hvivo.com. The company can be reached via phone at +44-20-77561300. This page (LON:HVO) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.